Cardiovascular action of mesoionic compounds, 3-substituted sydnonimines.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001011:Aorta; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006325:Heart Atria; D006339:Heart Rate / Q000187:drug effects; D007082:Ileum; D007097:Imines / Q000494:pharmacology; D066298:In Vitro Techniques; D007866:Leg / Q000098:blood supply; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010069:Oxadiazoles / Q000494:pharmacology*; D011817:Rabbits; D012039:Regional Blood Flow / Q000187:drug effects; D014132:Trachea; D014682:Vena Cava, Inferior
D000959:Antihypertensive Agents; D007097:Imines; D009025:Morpholines; D010069:Oxadiazoles